Search results

In short, the public is often worried about chemical exposure, as they should be when such exposure exceeds a safe dose. The public’s interest is best served by trusting experts dedicated to public health protection and not by withholding scientific data from independent analysis.

Two of the experimental coronavirus drugs, chloroquine, and hydroxychloroquine are a breeze to synthesize. But remdesivir, possibly the most promising candidate, is anything but. It's a royal pain. Here's why.

In the Digital Age, we have access to more information than at any time in human history. But that doesn't stop the spread of conspiracy theories. Here are the best (worst?) ones involving the new coronavirus and the disease COVID-19.

If there was any effect of this drug on COVID-19, it was minimal. Hydroxychloroquine, whose toxicity is far lower, may be safer than chloroquine. But that doesn't matter if the drugs are ineffective.

As the number of patients requiring ventilatory assistance to survive COVID-19 rises, and with no new ventilators in sight, a "Hail Mary" technique is starting to be used. Can a machine designed to help one patient be reconfigured to support two or more? And can it protect society at large, even just a bit, from surging hospital admissions?

On tap this time: Why coronavirus containment failed, learning from history, and how COVID-19 hijacks your body. Also, a ritual in troubled times ... giving moss the attention it deserves ... and finally, the reason to slack off. (There had to be a good reason, right?)

Peter Fairley, an environmental journalist and contributing editor for MIT Technology Review, cited an anti-vaccine website, DeSmogBlog, in a smear directed at our organization. Simultaneously, he spread misinformation about influenza and COVID-19 and endorses advice that contradicts that of the CDC and World Health Organization.

For those of you staying at home who might be considering performing CPR, a tracheostomy, or intubating someone in the neighborhood [1], an N95 mask is a necessity; otherwise, you are diverting "war-time" supplies from the first responder and health care army.

DeSmogBlog, a climate activist website that ruthlessly smears scientists, is headed by Brendan DeMelle, an anti-vaxxer who helped RFK, Jr. write an infamous and since-retracted article linking vaccines to autism.

"You never let a serious crisis go to waste. And what I mean by that it's an opportunity to do things you think you could not do before." -- Rahm Emmanuel [1]

The website’s strategy is clear: Throw ad hominem attacks as early and as often as possible. Why? Because it works. And the people most eager to spread the lies are self-proclaimed skeptical scientists and journalists.

Chloroquine, the old malaria drug, is making news as a potential therapy for coronavirus. Does it belong in the headlines for its antiviral properties, or is it just hype and bluster? Will it become a drug? Let's find out.

One way in which COVID-19 is not novel is that the disease follows a set pattern: first onset, then the body’s response, followed (hopefully) by recovery. To get a better sense of how this pandemic might play out, we should consider what we know about COVID-19’s timeline. 

At the current time, influenza remains the far bigger threat to global public health than COVID-19. Though COVID-19 has a higher case-fatality rate, influenza infects far more people. Of course, that could change.

As the horror known as the coronavirus tightens its grip on the world, and a vaccine is years away, our best hope is an antiviral drug that minimizes the damage caused by coronavirus replication. New data on favipiravir, a repurposed drug originally discovered in Japan, looks promising in trials in China. But nothing is ever straightforward in drug discovery -- and that is no different here. Here's a summary of the new findings.

Here's what's on tap: The how-to of COVID-19 testing ... an extremely well-informed skeptic wonders about our pandemic actions ... a possible silver lining to the massive economic fallout ... and what's behind the long lines of climbers trying to summit Mount Everest?

Testing performs both diagnostic and treatment roles, and testing for COVID-19 is no exception. Unlike other forms of testing, knowing your COVID-19 status will not alter your disease course or modify specific therapy. But it will determine where you spend the next few weeks, either at home or the hospital.

Extraordinary times call for extraordinary measures. But these kinds of measures can't last forever. The public is willing to tolerate massive disruptions to daily life only when it believes the disruptions will end. Therefore, mitigation is a more viable option.

"Journalists" Sharon Kelly of DeSmogBlog and Lee Fang of The Intercept are spreading disinformation about ACSH and COVID-19.

Dr. David Shlaes' primary expertise is in bacterial infections and antibiotics. So it's not surprising that our ACSH advisor is wondering about secondary bacterial infections from coronavirus infections. Will there be antibiotics to combat the infections this time? How about next time?

Consuming a huge meal to start the day, in order to lose weight, is an old adage. Does this belief stand up to science? Angela Dowden, our expert nutritionist, takes a closer look.

Dr. David Shlaes, an infectious disease expert and ACSH advisor, is incensed over the nation's lack of preparedness for the coronavirus epidemic. A scenario like this has been discussed for three decades, yet we are still in the middle of a disaster. Here are his thoughts.

Balance is an intricate “dance” of multiple sensory inputs. But what happens when one of them stops working as well as it should? As it turns out, hearing loss has unanticipated consequences.

There are two false narratives emerging on social media that need to be addressed. The first is that the virus is a hoax. The second is that the U.S. is "the next Italy." Both are wrong.

A blood alcohol concentration (BAC) of 0.08% while driving is considered impaired, and it's associated with an increase in motor vehicle accidents. But what about a “quick pop”? You know, being buzzed? How does that figure into the thinking? A new study sifts through the data.